Canadian cancer trials network for better, faster patient-ready trials
Official title: Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network
Funded at Queen's University at Kingston · NIH-11291260 · Data updated 2026-11-12
A national network in Canada partners with the US to speed up and improve cancer trials so patients get access to better treatments sooner.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Queen's University at Kingston NIH-funded |
| Lab location | 1 site (Kingston, Canada) |
| Project start | May 6, 2014 |
| Project end | February 29, 2032 |
| Funding year | 2026 |
| Award (this year) | $383,117 |
| NIH project number | 2U10CA180863-12 |
| Project ID | NIH-11291260 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults and adolescents with cancer who may benefit from participation in network-supported trials, including those with rare cancer types or requiring precision-medicine approaches.
✕Less likely to help
Patients with cancers not eligible for any ongoing network trials or those unable to participate due to medical or logistical reasons may not benefit.
What this research studies
This grant supports a collaborative network that designs and runs cancer trials across Canada and with international partners. It aims to modernize trial design and delivery as new molecular insights and therapies emerge, with a focus on rare cancers and precision medicine. The effort includes leadership roles, expanding trial capacity, and collecting biospecimens to advance science and patient care. By coordinating clinics nationwide, it seeks to bring innovative treatments to more patients and to streamline participation in cutting-edge studies.
Why it matters
Potential benefit: Could accelerate access to innovative cancer treatments and improve trial quality for patients.
How similar studies have gone: Other international cancer trial networks have shown success in completing trials faster and advancing patient care through collaboration and shared protocols.
Where this research is happening
-
Queen's University at Kingston
Kingston, Canada Active
Researchers
- Principal investigator: Dancey, Janet Ellen — Queen's University at Kingston
- Study coordinator: Dancey, Janet Ellen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.